- Home
- MEDP vs NIO Comparison
MEDP vs NIO Comparison
Compare MEDP & NIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- NIO
- Stock Information
- Founded
- MEDP 1992
- NIO 2014
- Country
- MEDP United States
- NIO China
- Employees
- MEDP N/A
- NIO N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- NIO Auto Manufacturing
- Sector
- MEDP Health Care
- NIO Consumer Discretionary
- Exchange
- MEDP Nasdaq
- NIO Nasdaq
- Market Cap
- MEDP 11.7B
- NIO 11.0B
- IPO Year
- MEDP 2016
- NIO 2018
- Fundamental
- Price
- MEDP $342.89
- NIO $5.16
- Analyst Decision
- MEDP Buy
- NIO Buy
- Analyst Count
- MEDP 10
- NIO 11
- Target Price
- MEDP $402.44
- NIO $7.35
- AVG Volume (30 Days)
- MEDP 385.5K
- NIO 95.4M
- Earning Date
- MEDP 10-21-2024
- NIO 12-03-2024
- Dividend Yield
- MEDP N/A
- NIO N/A
- EPS Growth
- MEDP 27.33
- NIO N/A
- EPS
- MEDP 10.64
- NIO N/A
- Revenue
- MEDP $2,030,048,000.00
- NIO $8,741,599,705.00
- Revenue This Year
- MEDP $15.81
- NIO $26.98
- Revenue Next Year
- MEDP $12.91
- NIO $46.04
- P/E Ratio
- MEDP $32.21
- NIO N/A
- Revenue Growth
- MEDP 21.36
- NIO 30.94
- 52 Week Low
- MEDP $227.21
- NIO $3.61
- 52 Week High
- MEDP $459.77
- NIO $9.57
- Technical
- Relative Strength Index (RSI)
- MEDP 46.60
- NIO 39.50
- Support Level
- MEDP $331.32
- NIO $5.98
- Resistance Level
- MEDP $357.10
- NIO $6.45
- Average True Range (ATR)
- MEDP 8.70
- NIO 0.41
- MACD
- MEDP 2.17
- NIO -0.21
- Stochastic Oscillator
- MEDP 58.00
- NIO 3.95
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About NIO NIO Inc. American depositary shares each representing one ordinary share
Nio is a leading electric vehicle maker, targeting the premium segment. Founded in November 2014, Nio designs, develops, jointly manufactures, and sells premium smart electric vehicles. The company differentiates itself through continuous technological breakthroughs and innovations such as battery swapping and autonomous driving technologies. Nio launched its first model, its ES8 seven-seater electric SUV, in December 2017, and began deliveries in June 2018. Its current model portfolio includes midsize to large sedans and SUVs. It sold over 160,000 EVs in 2023, accounting for about 2% of the China passenger new energy vehicle market.